Discover 2,012 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
for
Prostate Cancer
Location: New York NY, New Brunswick NJ, Ann Arbor MI, Madison WI
Sponsor: Genta Incorporated
Sex: Male
Age: 18+
Code: NCT01296243
Phase2, Recruiting
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
for
HER2-negative Breast Cancer
Location: Newark NJ, Baltimore MD, York PA, Mechanicsville VA,
Sponsor: NSABP Foundation Inc
Sex: Female
Age: 18+
Code: NCT03412643
Phase2, Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Lebanon NH, New Hyde Park NY, Neptune City NJ,
Sponsor: United Therapeutics
Sex: All
Age: 18+
Code: NCT06388421
Recruiting
SPIROMICS Study of Early COPD Progression (SOURCE)
for
COPD, Early-Onset
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: University of Massachusetts, Worcester
Sex: All
Age: 30 - 55
Code: NCT05033990
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Location: Boston MA, Worcester MA, New Haven CT, Stony Brook NY,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05735184
Phase1, Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Fairhaven MA, Boston MA, Stony Brook NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase3, Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Boston MA, Westbury NY, New York NY, Washington D.C. DC,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase1, Phase2, Recruiting
Molecular Responses Caused by UV Exposure of Human Skin
for
Ultraviolet Light Burn
Location: Ann Arbor MI
Sponsor: Access Business Group
Sex: Female
Age: 20 - 50
Code: NCT05383664
Early_phase1, Recruiting
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease